Pharmacy Times

NOVEMBER 9, 2023

Women with inflammation during COVID-19 infection are at higher risk for Long Covid symptoms, according to study results.

175

175

STAT

NOVEMBER 9, 2023

MEXICO CITY — More than 5.6 million U.S. tourists head to Cancun every year, drawn to the Mexican port’s white sand beaches, all-inclusive resorts, and raucous nightlife. Soon there’s likely to be another reason to visit: MSI Reproductive Choices , an international reproductive health nonprofit, plans to open an abortion clinic in the city, partly designed to cater to travelers from the U.S. who are unable to get an abortion in their home states.

145

145

Pharmacy Times

NOVEMBER 9, 2023

With this approval, fruquintinib is the first and only selective inhibitor of all 3 VEGR receptor kinases to be approved in the United States for previously treated mCRC, regardless of biomarker status.

FDA 139

FDA 139

STAT

NOVEMBER 9, 2023

In my decade living in Silicon Valley as a digital health journalist and now an investor, I can’t tell you how many times I’ve heard people in the tech industry claim that doctors don’t have what it takes for a career in entrepreneurship. As the traditional thinking goes, because they’re so risk-averse and lack business training, physicians are not well suited to a high-growth, venture-backed startup environment.

145

145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

NOVEMBER 9, 2023

Pharmacists are accessible and trusted health care professionals who have an important role in supporting people living with mental illness.

153

153

STAT

NOVEMBER 9, 2023

A panel of government advisers finally has endorsed ideas for Congress to solve the particularly thorny problem of surprise ambulance bills , including a cap on how much patients would have to pay if they took an ambulance. Surprise bills have been eliminated for most health care services, but people who take out-of-network ground ambulances remain broadly unprotected — facing potentially thousands of dollars and the threat of collections for a ride that nobody really asks for.

Hospitals 143

Hospitals 143

STAT

NOVEMBER 9, 2023

Maybe probiotics would have saved my son’s life. I’ll never know because when I asked Micah’s care team to consider probiotics to counter the deluge of antibiotics, I was dismissed as senseless. My son Micah was born at 27 weeks gestation, weighing just over 2 pounds, with a head full of thick, wavy hair. By 6 weeks old, Micah weighed 5 pounds, was beginning to nurse, and was progressing toward discharge.

FDA 141

FDA 141

Pharmacy Times

NOVEMBER 9, 2023

Socioeconomic, racial, and insurance disparities impact individuals' health before and after receiving surgery to treat adolescent idiopathic scoliosis.

Insurance 130

Insurance 130

STAT

NOVEMBER 9, 2023

When Jason Farley was growing up in rural Alabama as a young gay man, he faced a lot of prejudice. “Everything I heard was like I was going to wake up one day and God was going to smite me with AIDS,” he said.

137

137

Pharmacy Times

NOVEMBER 9, 2023

Perfluorohexyloctane is the first and only treatment that targets tear evaporation to provide relief for dry eye disease

145

145

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

NOVEMBER 9, 2023

Apple has for years promised that its devices can help people live healthier, but it has so far produced little concrete evidence of this benefit. Many of the company’s health tools are consumer features without strong ties to the health care system, so there often isn’t a health care outcome to measure as proof. Nevertheless, Apple has embarked on several systematic studies exploring how its devices might be used to more directly improve health conditions, and after several years,

Insurance 135

Insurance 135

Drug Topics

NOVEMBER 9, 2023

Because of misclassification of diabetes type and the absence of distinction between risk factors, such as birth weight, and diabetes type, uncertainty exists regarding the relationship between obesity and T1D.

98

98

STAT

NOVEMBER 9, 2023

NEW YORK — Surgeons have performed the world’s first transplant of an entire human eye, an extraordinary addition to a face transplant — although it’s far too soon to know if the man will ever see through his new left eye. An accident with high-voltage power lines had destroyed most of Aaron James’ face and one eye.

133

133

Pharmacy Times

NOVEMBER 9, 2023

Preventative drug lists were associated with a modest increase in adherence to combination inhaled corticosteroid long-acting β2-agonists.

132

132

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

The Checkup by Singlecare

NOVEMBER 9, 2023

The U.S. Food and Drug Administration (FDA) just approved Zepbound (tirzepatide) for chronic weight management. The injectable medication is a new version of Eli Lilly’s Mounjaro, which is approved by the FDA to control blood sugar in people with Type 2 diabetes. Studies show tirzepatide works as an effective drug for people with obesity or those who are overweight and have other health conditions.

FDA 120

FDA Insurance Labelling 120

Pharmacy Times

NOVEMBER 9, 2023

More individuals with systemic lupus erythematosus treated with anifrolumab-fnia reached remission compared to the placebo.

139

139

Fierce Healthcare

NOVEMBER 9, 2023

Optum Rx is shifting eight different insulin products to its preferred formulary in a bid to address affordability, the company said Thursday. | Optum Rx is shifting eight different insulin products to its preferred formulary in a bid to address affordability, the company said Thursday.

115

115

STAT

NOVEMBER 9, 2023

What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them.

112

112

Fierce Healthcare

NOVEMBER 9, 2023

Financial struggles at Bright Health Group and Friday Health Plans have raised concerns about how well the Affordable Care Act's (ACA's) risk adjustment program is working, especially whether it's | Financial struggles at Bright Health Group and Friday Health Plans have raised concerns about how well the Affordable Care Act's risk adjustment program is working, especially whether it's unfairly harming smaller insurers.

Insurance 110

Insurance 110

Fierce Pharma

NOVEMBER 9, 2023

Thanks to a Takeda approval Thursday, patients now have a drug to tackle a rare inherited blood clotting disorder. | The FDA has given a green light to Takeda’s Adzynma, the first recombinant protein product as a preventative or on demand enzyme replacement therapy in adults and kids with congenital thrombotic thrombocytopenic purpura.

FDA 110

FDA 110

European Pharmaceutical Review

NOVEMBER 9, 2023

Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders. In July 2023, MyMD Pharmaceuticals released results from its Phase II study in sarcopenia evaluating potential of MYMD-1 ® , its first-in-class oral TNF-α inhibitor.

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies Immunization Process Improvement 110

Fierce Healthcare

NOVEMBER 9, 2023

As pharmacy workers begin efforts to unionize, Walgreens Boots Alliance Executive Vice President and President of U.S. | Amid labor unrest and slipping financial performance, Walgreens executive John Driscoll said the company will be investing in salary and benefits improvements for its pharmacy workers.

110

110

European Pharmaceutical Review

NOVEMBER 9, 2023

Sandoz and Teva have become the first organisations to qualify for the new global Minimized Risk of Antimicrobial Resistance (AMR) certification. This programme was developed by the British Standards Institute (BSI) to verify companies that are taking the necessary steps in ensuring responsible antibiotic manufacturing in the global supply chain, helping to lower the spread of AMR.

108

108

The Checkup by Singlecare

NOVEMBER 9, 2023

If you’ve ever had a sinus infection, you know how painful it can be. Symptoms like a stuffy nose, pressure or pain behind the eyes, headaches, a cough, and a sore throat, can have you looking for quick relief. The good news is there are a few ways to ease your symptoms. Sinus infections, or sinusitis, occur when the sinuses become infected with a virus or bacteria, making it difficult for mucus to drain.

Immunization 106

Immunization Mayo Clinic Hospitals Communication 106

PharmaVoice

NOVEMBER 9, 2023

A gene editing therapy developed by Vertex Pharmaceuticals and CRISPR Therapeutics can mute sickle cell disease’s most damaging symptoms. Yet treatment may not be as simple as its dramatic benefit makes it seem.

98

98

STAT

NOVEMBER 9, 2023

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. And then there were five (well, six) A pared-back field of five GOP presidential candidates sparred Wednesday night, touching on health issues ranging from hot-button election topics, to wonky budget math.

Hospitals 98

Hospitals 98

Drug Store News

NOVEMBER 9, 2023

Bubble Skincare’s new Morning Rays Brightening Eye Cream is formulated with ingredients that can help brighten dark circles and reduce inflamed and puffy skin under the eyes, the brand said.

98

98

Hospital Pharmacy Europe

NOVEMBER 9, 2023

Electronic product information (ePI) for selected human medicines has been published for the first time by the Heads of Medicines Agencies (HMA), the European Commission (EC) and the European Medicines Agency (EMA). Publishing this critical information on how medicines should be prescribed and used in an electronic format marks a step towards more digitally enabled healthcare systems and provides consistency across all EU Member States.

Adverse Reactions 97

Adverse Reactions Pharmaceutical Companies Pharmaceutical Companies Hospitals 97

Fierce Pharma

NOVEMBER 9, 2023

AstraZeneca licensed an oral GLP-1 agonist from China's Eccogene. Takeda won FDA approval for the Hutchmed-developed colorectal cancer drug Fruzaqla. | AstraZeneca licensed an oral GLP-1 agonist from China's Eccogene. Takeda won FDA approval for Hutchmed-developed colorectal cancer drug Fruzaqla. BioNTech bought a PD-L1xVEGF bispecific antibody from Chinese biotech Biotheus.

FDA 97

FDA 97

Drug Topics

NOVEMBER 9, 2023

Mebella is another weapon in the global fight to eradicate these diseases.

Vaccines 123

Vaccines 123

Drug Store News

NOVEMBER 9, 2023

With so many new products hitting shelves this year, CEW and its members have taken it upon themselves to find the standouts of 2023.

111

111

STAT

NOVEMBER 9, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a counterintuitive idea in pharma, an ode to scientific matrimony, and the solution to a CAR-T mystery.

94

94

Pharmacy Times

NOVEMBER 9, 2023

Launching development of SOPs and communication with wholesalers is key.

Communication 136

Communication 136

Drug Store News

NOVEMBER 9, 2023

Amazon is expanding Amazon Fresh grocery delivery and pickup to all customers, while unveiling re-imagined Amazon Fresh stores in Los Angeles.

105

105